Bossi P - Search Results

1

Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers.

Esposito A, Stucchi E, Baronchelli M, Di Mauro P, Ferrari M, Lorini L, Gurizzan C, London NRJ, Hermsen M, Lechner M, Bossi P. Esposito A, et al. Among authors: bossi p. J Clin Med. 2022 Nov 16;11(22):6787. doi: 10.3390/jcm11226787. J Clin Med. 2022. PMID: 36431263 Free PMC article. Review.

2

Management of sinonasal adenocarcinomas with anterior skull base extension.

Ferrari M, Bossi P, Mattavelli D, Ardighieri L, Nicolai P. Ferrari M, et al. Among authors: bossi p. J Neurooncol. 2020 Dec;150(3):405-417. doi: 10.1007/s11060-019-03385-8. Epub 2020 Jan 3. J Neurooncol. 2020. PMID: 31897925 Review.

3

Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients.

Ferrari M, Ioppi A, Schreiber A, Gualtieri T, Mattavelli D, Rampinelli V, Taboni S, Tomasoni M, Bossi P, Deganello A, Nicolai P. Ferrari M, et al. Among authors: bossi p. Oral Oncol. 2020 Jul;106:104672. doi: 10.1016/j.oraloncology.2020.104672. Epub 2020 Apr 13. Oral Oncol. 2020. PMID: 32298995

4

Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm.

Bossi P, Hermsen M, Lechner M, Franchi A. Bossi P, et al. Oral Oncol. 2020 Oct;109:104737. doi: 10.1016/j.oraloncology.2020.104737. Epub 2020 Apr 25. Oral Oncol. 2020. PMID: 32340860 No abstract available.

5

Treatment Options for Recurrent Anterior Skull Base Tumors.

Orlandi E, Iacovelli NA, Ingargiola R, Resteghini C, Bossi P, Licitra L, Ferrari M, Nicolai P. Orlandi E, et al. Among authors: bossi p. Adv Otorhinolaryngol. 2020;84:231-245. doi: 10.1159/000457942. Epub 2020 Jul 30. Adv Otorhinolaryngol. 2020. PMID: 32731228 Review.

6

Future Perspectives in the Management of Tumors of the Anterior Skull Base.

Nicolai P, Bradley PJ, Bossi P, Ferrari M. Nicolai P, et al. Among authors: bossi p. Adv Otorhinolaryngol. 2020;84:246-250. doi: 10.1159/000457943. Epub 2020 Jul 30. Adv Otorhinolaryngol. 2020. PMID: 32731229 Review.

7

The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing.

Mattavelli D, Ferrari M, Taboni S, Morello R, Paderno A, Rampinelli V, Del Bon F, Lombardi D, Grammatica A, Bossi P, Deganello A, Piazza C, Nicolai P. Mattavelli D, et al. Among authors: bossi p. Oral Oncol. 2020 Dec;111:104937. doi: 10.1016/j.oraloncology.2020.104937. Epub 2020 Aug 1. Oral Oncol. 2020. PMID: 32750558

8

Brain metastasis in head and neck squamous cell carcinoma after immune check point inhibitors treatment.

Lorini L, Merlano M, Licitra L, Ravanelli M, Bossi P. Lorini L, et al. Among authors: bossi p. Oral Oncol. 2021 May;116:105138. doi: 10.1016/j.oraloncology.2020.105138. Epub 2020 Dec 31. Oral Oncol. 2021. PMID: 33390267 No abstract available.

9

Oral potentially malignant disorders: new insights for future treatment.

Gurizzan C, Lorini L, Bossi P. Gurizzan C, et al. Among authors: bossi p. Curr Opin Otolaryngol Head Neck Surg. 2021 Apr 1;29(2):138-142. doi: 10.1097/MOO.0000000000000695. Curr Opin Otolaryngol Head Neck Surg. 2021. PMID: 33394736 Review.

10

Sinonasal cancer encroaching the orbit: Ablation or preservation?

Ferrari M, Migliorati S, Tomasoni M, Crisafulli V, Nocivelli G, Paderno A, Rampinelli V, Taboni S, Schreiber A, Mattavelli D, Lancini D, Gualtieri T, Ravanelli M, Facchetti M, Bozzola A, Ardighieri L, Maroldi R, Bossi P, Farina D, Battocchio S, Deganello A, Nicolai P. Ferrari M, et al. Among authors: bossi p. Oral Oncol. 2021 Mar;114:105185. doi: 10.1016/j.oraloncology.2021.105185. Epub 2021 Jan 28. Oral Oncol. 2021. PMID: 33517131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

579 results

Search Page